IRIS
ZENTILIN, PATRIZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 20.960
AS - Asia 700
SA - Sud America 133
NA - Nord America 91
AF - Africa 14
Totale 21.898
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 20.931
SG - Singapore 275
CN - Cina 213
VN - Vietnam 149
BR - Brasile 86
US - Stati Uniti d'America 65
AR - Argentina 25
HK - Hong Kong 23
MX - Messico 17
EC - Ecuador 10
IN - India 9
CA - Canada 8
ID - Indonesia 8
BD - Bangladesh 7
GB - Regno Unito 7
IQ - Iraq 7
DE - Germania 5
VE - Venezuela 5
ES - Italia 4
CO - Colombia 3
RU - Federazione Russa 3
LT - Lituania 2
NL - Olanda 2
PH - Filippine 2
PK - Pakistan 2
PL - Polonia 2
PY - Paraguay 2
UG - Uganda 2
ZA - Sudafrica 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CL - Cile 1
DZ - Algeria 1
EG - Egitto 1
GA - Gabon 1
GT - Guatemala 1
IE - Irlanda 1
JP - Giappone 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
LY - Libia 1
MY - Malesia 1
NG - Nigeria 1
PE - Perù 1
SN - Senegal 1
TG - Togo 1
TN - Tunisia 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 21.898
Salva come PNG Salva come JPEG
Città #
Genova 12.851
Genoa 4.934
Rapallo 1.742
Vado Ligure 1.357
Singapore 109
Beijing 68
Ho Chi Minh City 60
Bordighera 34
Hanoi 34
Ashburn 25
Hong Kong 23
Tianjin 15
Mexico City 12
Haiphong 6
Orem 6
Chennai 5
Montreal 5
New York 5
Quito 5
São Paulo 5
Da Nang 4
Baghdad 3
Hải Dương 3
Poplar 3
Rio de Janeiro 3
Salvador 3
Thái Bình 3
Thái Nguyên 3
Bandung 2
Brasília 2
Brugherio 2
Bắc Giang 2
Chicago 2
Curitiba 2
Córdoba 2
Dhaka 2
Fortaleza 2
Frankfurt am Main 2
Guangzhou 2
Guayaquil 2
Hanau 2
Kampala 2
Lomas de Zamora 2
Los Angeles 2
Manchester 2
Maracaibo 2
Mediglia 2
Milan 2
Ninh Bình 2
Ourinhos 2
Quảng Ngãi 2
Rome 2
Salt Lake City 2
San Jose 2
Sorocaba 2
Toronto 2
Warsaw 2
Wuhan 2
Abidjan 1
Almirante Tamandaré 1
Andradina 1
Atibaia 1
Atlanta 1
Balashikha 1
Basra 1
Batam 1
Betim 1
Bismarck 1
Biên Hòa 1
Blumenau 1
Bogotá 1
Boisar 1
Bologna 1
Bonito de Santa Fé 1
Boston 1
Britânia 1
Brooklyn 1
Buenos Aires 1
Bảo Lộc 1
Bến Cầu 1
Cachoeira do Sul 1
Cagliari 1
Campo Largo 1
Campos Gerais 1
Can Tho 1
Carapicuíba 1
Carlópolis 1
Casa Nova 1
Cebu City 1
Centro 1
Chacabuco 1
Changsha 1
Chapecó 1
Charallave 1
Chernichenskiye Dvory 1
Ciudad Juárez 1
Cleveland 1
Colônia Leopoldina Municipality 1
Constantine 1
Dakar 1
Totale 21.428
Salva come PNG Salva come JPEG
Nome #
Hepatobiliary and Pancreatic: A rare cause of portal hypertension. 231
Characteristics of gastro-esophageal reflux episodes in Barrett's esophagus, erosive esophagitis and healthy volunteers 201
Proton pump inhibitors: use and misuse in the clinical setting 199
Time pattern of gastric acidity in Barrett's esophagus 191
A pharmacodynamic study of two omeprazole regimens suitable for long-term treatment of duodenal ulcer. 190
Not All Patients With Non-erosive Reflux Disease Share Psychological Distress as Main Mechanism of Disease. 184
Circadian pattern of intragastric acidity in patients with non-erosive reflux disease (NERD) 183
Reassessment of the diagnostic value of histology in patients with GERD, using multiple biopsy sites and an appropriate control group 182
Advancements in the use of manometry and impedance testing for esophageal functional disorders 181
Outcome of nonerosive gastro-esophageal reflux disease patients with pathological acid exposure. 177
Alginate controls heartburn in patients with erosive and nonerosive reflux disease. 177
A comparison of the effects on intragastric acidity of bedtime or dinnertime administration of a once daily dose of famotidine. 176
A safety review of proton pump inhibitors to treat acid-related digestive diseases 176
A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD) 175
The relevance of symptom association analysis in GORD patients undergoing anti-reflux surgery 173
Pathophysiology, diagnosis, and pharmacological treatment of gastro-esophageal reflux disease 173
A comparison between sodium alginate and magaldrate anhydrous in the treatment of patients with gastroesophageal reflux symptoms. 172
The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease. 170
Cell proliferation of squamous epithelium in gastro-oesophageal reflux disease: correlations with clinical, endoscopic and morphological data 165
Improvement in esophageal motor abnormalities in systemic sclerosis patients treated with cyclosporine: comment on the article by Clements et al. 164
Drugs for improving esophageal mucosa defense: Where are we now and where are we going? 164
24-hour gastric pH and extent of duodenal gastric metaplasia in Helicobacter pylori-positive patients. 163
Are duodenal ulcer seasonal fluctuations paralleled by seasonal changes in 24-hour gastric acidity and Helicobacter pylori infection? 161
An evaluation of the antireflux properties of sodium alginate by means of combined multichannel intraluminal impedance and pH-metry. 160
Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn. 160
A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial 159
Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease. 159
Antimony and glass pH electrodes can be used interchangeably in 24-hour studies of gastric acidity. 155
Antisecretory effects of three omeprazole regimens for maintenance treatment in duodenal ulcer. 155
Absence of tolerance in duodenal ulcer patients treated for 28 days with a bedtime dose of roxatidine or ranitidine. 154
Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients. 153
New insight in the mechanism of omeprazole antimicrobial combinations to eradicate Helicobacter pylori. 150
Once and twice daily doses of H2 antagonists revisited, using continuous intragastric pH monitoring. 148
Microscopic esophagitis in gastro-esophageal reflux disease: individual lesions, biopsy sampling, and clinical correlations 148
Circadian acidity pattern in prepyloric ulcers: a comparison with normal subjects and duodenal ulcer patients. 147
NERD: an umbrella term including heterogeneous subpopulations. 147
Cyclosporin A and iloprost treatment of systemic sclerosis: clinical results and interleukin-6 serum changes after 12 months of therapy. 146
Microscopic Esophagitis is More Frequent in Patients With pH-Positive Non-Erosive Reflux Disease and Hypersensitive Esophagus Than in Those With Functional Heartburn: A Study Using Impedance-pH and Optical Microscopy. 146
Achalasia with Dense Eosinophilic Infiltrate Responding To Steroidal Treatment. 145
Low bedtime doses of H2-receptor antagonists for acute treatment of duodenal ulcer. 145
Circadian gastric acidity in Helicobacter pylori positive ulcer patients with and without gastric metaplasia in the duodenum. 144
Endotherapy for and tailored approaches to treating GERD, and refractory GERD 142
Esophageal biopsies in the management of GERD: complementary tool for many but not for all. 142
Air swallowing can be responsible for non-response of heartburn to high-dose proton pump inhibitor. 139
Negative effect of ranitidine on the results of urea breath test for the diagnosis of Helicobacter pylori 138
Effect of gastric acid suppression on 13C-urea breath test: comparison of ranitidine with omeprazole. 138
Helicobacter pylori and tolerance to H2-blockers. 137
Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole 137
24-hour study of gastric acidity in normal subjects and in cholecystectomized patients using continuous pH monitoring. 136
The appropriate use of proton-pump inhibitors 136
Esophageal acid exposure still plays a major role in patients with NERD. 135
Antisecretory effect of three premeal doses of cimetidine 400 mg versus a single morning dose of omeprazole 20 mg: pathophysiological implications for duodenal ulcer treatment. 134
Helicobacter pylori infection is not involved in the pathogenesis of either erosive or non-erosive gastro-oesophageal reflux disease. 133
The relevance of weakly acidic reflux in patients with Barrett's esophagus. 131
Epidemiology and natural history of gastroesophageal reflux disease 131
Eradication of Helicobacter pylori may reduce disease severity in rheumatoid arthritis. 130
Innovative techniques in evaluating the esophagus; imaging of esophageal morphology and function; and drugs for esophageal disease. 130
Low Fibrinogen Levels Are Associated with Bleeding After Varices Ligation in Thrombocytopenic Cirrhotic Patients 130
Reduction of hexavalent chromium by fasted and fed human gastric fluid. I. Chemical reduction and mitigation of mutagenicity 130
Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy. 129
Studies on factors predicting GORD response to proton-pump inhibitors: NERD subpopulations need to be analysed separately. 129
Carditis in patients with gastro-oesophageal reflux disease: results of a controlled study based on both endoscopy and 24-h oesophageal pH monitoring. 128
Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients. 127
24-hour gastric pH-metry analysis: influence of arbitrarily predefined time intervals on the reliability of acidity indexes. 126
Is Helicobacter pylori infection a risk factor for disease severity in rheumatoid arthritis? 125
The role of Acid in functional dyspepsia. 125
Comparable Helicobacter pylori eradication rates obtained with 4- and 7-day rabeprazole-based triple therapy: a preliminary study 124
Evaluation of 24-hour gastric acidity in patients with hepatic cirrhosis. 123
MIB-1 Proliferation Index of squamous epithelium in gastroesophageal reflux disease. Correlations with clinical, Endoscopic and Morphological data. 122
Clinical relevance of sampling rate in the characterization and analysis of 24-hour gastric acidity. A report on 413 cases. 122
Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording. 121
[Esophageal pH monitoring: factors influencing the definition of normality]. 121
The effects of omeprazole 20 and 40 mg twice daily on intragastric acidity in duodenal ulcer patients. 121
Combined multichannel intraluminal impedance and pH-metry: a novel technique to improve detection of gastro-oesophageal reflux literature review. 120
Lactulose breath test to assess oro-cecal transit delay and estimate esophageal dysmotility in scleroderma patients. 120
Failure of new diagnostic aids in improving detection of pancreatic cancer at a resectable stage. 120
Relevance of measuring substances in bronchoalveolar lavage fluid for detecting aspiration-associated extraesophageal reflux disease 120
Nonerosive reflux disease and functional heartburn are clearly separate entities. 119
Non-erosive reflux disease is more complex than negative endoscopy only. 118
Basal cell hyperplasia and dilatation of intercellular spaces are the main histologic features associated to the endoscopic/impedance-pH diagnosis of GERD and its related mucosal integrity impairment 118
Functional testing: pharyngeal pH monitoring and high-resolution manometry. 117
Improvement in hepatitis C virus patients with advanced, compensated liver disease after sustained virological response to direct acting antivirals 117
Appropriateness of proton pump inhibitors treatment in clinical practice: Prospective evaluation in outpatients and perspective assessment of drug optimisation 117
Pathophysiological characteristics of long- and short-segment Barrett's oesophagus. 116
The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori. 116
Esophageal baseline impedance levels allow the identification of esophageal involvement in patients with systemic sclerosis 116
Is gastric acid hypersecretion the only reason for refractory gastroesophageal reflux disease? 115
Comment to "current applications of evolving methodologies in gastroesophageal reflux disease testing". 115
Pathophysiological studies are mandatory to understand the benefit of proton pump inhibitors in patients with idiopathic pulmonary fibrosis 115
Normal values of 24-h ambulatory intraluminal impedance combined with pH-metry in subjects eating a Mediterranean diet. 115
Comparison of 24-h control of gastric acidity by three different dosages of pantoprazole in patients with duodenal ulcer. 114
Stool antigen assay (HpSA) is less reliable than urea breath test for post-treatment diagnosis of Helicobacter pylori infection. 114
Esophagogastric junction morphology is associated with a positive impedance-pH monitoring in patients with GERD 114
Analysis of circadian fluctuations of bile salt concentration and pH in the stomach of normal subjects and patients suspected of having duodenogastric reflux. 114
Pathophysiological characteristics of patients with non-erosive reflux disease differ from those of patients with functional heartburn. 113
Esophageal acid exposure still plays a major role in patients with NERD. 113
Ulcer healing: does omeprazole efficacy depend on daytime or 24-hour acid inhibition? 113
Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring. 112
Nocturnal reflux and sleep disturbances: an overlooked link in the past. 111
Once-Daily Bedtime Dose of Roxatidine and Ranitidine in Acute Duodenal Ulcer: A Combined Assessment of Acid Inhibitory Activity and Healing Rate. 110
Totale 14.143
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.170
article - articoli 63.656
book - libri 462
conference - conferenze 890
curatela - curatele 0
other - altro 6.184
patent - brevetti 0
selected - selezionate 0
volume - volumi 978
Totale 144.340
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021846 0 0 0 0 0 127 88 149 147 138 97 100
2021/20222.102 107 156 179 282 75 144 163 405 82 210 65 234
2022/20232.094 223 130 21 190 442 312 1 167 367 13 203 25
2023/20241.019 49 123 24 115 94 157 64 49 59 21 83 181
2024/20253.309 160 253 152 206 440 331 284 494 133 133 360 363
2025/20262.706 728 157 447 576 652 146 0 0 0 0 0 0
Totale 22.155